Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8384271rdf:typepubmed:Citationlld:pubmed
pubmed-article:8384271lifeskim:mentionsumls-concept:C0006736lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C0036974lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C0678544lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C0302113lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8384271lifeskim:mentionsumls-concept:C1654900lld:lifeskim
pubmed-article:8384271pubmed:issue4lld:pubmed
pubmed-article:8384271pubmed:dateCreated1993-4-22lld:pubmed
pubmed-article:8384271pubmed:abstractTextA total of 100 whole stones was fragmented in vitro at 3-minute intervals with piezoelectric shock waves using the EDAP LT-01 device until all fragments were less than 2 mm. Larger stones and stones with a high computerized tomography attenuation needed longer treatments for fragmentation. Smoothly bulging stones with an even structure according to plain x-ray films were also more resistant to the shock wave treatment. Calcium oxalate monohydrate stones were not more difficult to break than other types of calculi. Stone fragments from 100 patients after extracorporeal shock wave lithotripsy were also analyzed. The average size of the fragments collected was less than 1 mm. Larger stones produced larger fragments and required more treatment sessions.lld:pubmed
pubmed-article:8384271pubmed:languageenglld:pubmed
pubmed-article:8384271pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8384271pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8384271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8384271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8384271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8384271pubmed:statusMEDLINElld:pubmed
pubmed-article:8384271pubmed:monthAprlld:pubmed
pubmed-article:8384271pubmed:issn0022-5347lld:pubmed
pubmed-article:8384271pubmed:authorpubmed-author:PetterssonSSlld:pubmed
pubmed-article:8384271pubmed:authorpubmed-author:HedelinHHlld:pubmed
pubmed-article:8384271pubmed:authorpubmed-author:WangY HYHlld:pubmed
pubmed-article:8384271pubmed:authorpubmed-author:ZachrissonB...lld:pubmed
pubmed-article:8384271pubmed:authorpubmed-author:WikholmGGlld:pubmed
pubmed-article:8384271pubmed:authorpubmed-author:GrenaboLLlld:pubmed
pubmed-article:8384271pubmed:issnTypePrintlld:pubmed
pubmed-article:8384271pubmed:volume149lld:pubmed
pubmed-article:8384271pubmed:ownerNLMlld:pubmed
pubmed-article:8384271pubmed:authorsCompleteYlld:pubmed
pubmed-article:8384271pubmed:pagination699-702lld:pubmed
pubmed-article:8384271pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:meshHeadingpubmed-meshheading:8384271-...lld:pubmed
pubmed-article:8384271pubmed:year1993lld:pubmed
pubmed-article:8384271pubmed:articleTitleAnalysis of stone fragility in vitro and in vivo with piezoelectric shock waves using the EDAP LT-01.lld:pubmed
pubmed-article:8384271pubmed:affiliationDepartment of Urology, Sahlgrenska Hospital, University of Göteborg, Sweden.lld:pubmed
pubmed-article:8384271pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8384271pubmed:publicationTypeIn Vitrolld:pubmed